Bupropion induces sniffing: a possible dopaminergic mechanism

Zarrindast, MohammadReza. and Hojjati, Mohammad reza. and Pejhan, Akbar. and Soleimannejad, Elaheh. (1996) Bupropion induces sniffing: a possible dopaminergic mechanism. European neuropsychopharmacology, 6 (4).

Full text not available from this repository.

Abstract

The effect of bupropion, an antidepressant drug, on sniffing behaviour was examined in rats. Animals treated intraperitoneally (i.p.) with different doses of bupropion (5-40 mg/kg) showed sniffing behaviour in a dose-related manner. Pretreatment of animals (i.p.) with the dopamine antagonists SCH 23390 (0.025-0.1 mg/kg) or sulpiride (12.5-50 mg/kg) decreased the sniffing induced by bupropion. Reserpine pretreatment (2.5 mg/kg, i.p., 18 h) alone and in combination with o~-methyl-p-tyrosine (AMPT; 250 mg/kg, i.p.) also reduced the behaviour produced by the drug. The et-adrenoceptor phenoxybenzamine (5 and 10 mg/kg, i.p.) and the [3-adrenoceptor antagonist propranolol (5 and 10 mg/kg, i.p.) administered 60 rain prior to bupropion did not affect the drug's effect on sniffing. Propranolol alone, however, induced sniffing. The antimuscarinic atropine (5 and 10 mg/kg, i.p.) administered 30 min prior to bupropion increased the bupropion response. Atropine alone induced vigorous sniffing. It is concluded that bupropion induced sniffing through a dopaminergic mechanism

Item Type: Article
Uncontrolled Keywords: Bupropion; Dopamine antagonists; Reserpine; a-Methyl-p-tyrosine; Sniffing; Rats
Subjects: QT physiology
QV pharmacology
Divisions: Faculty of Medicine > Basic Sciences Academic Groups > Department of Physiology
Depositing User: Users 1 not found.
Date Deposited: 02 Jan 2018 08:06
Last Modified: 05 Feb 2018 08:03
URI: http://eprints.skums.ac.ir/id/eprint/6787

Actions (login required)

View Item View Item